Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

I-MAB American Depositary Shares (IMAB)

https://www.i-mabbiopharma.com

I-Mab Biopharma is a clinical-stage biotech company in China that listed on Nasdaq in January 2020. Its first commercial drug will likely be eftansomatropin, a long-acting growth hormone that has a large market in China among pediatric patients with short stature, which we estimate will launch in 2024 or 2025. Other core assets include lemzoparlimab, a potential best-in-class CD47 inhibitor in phase 2 trials; uliledlimab, a potential best-in-class CD73 inhibitor in phase 2 trials; and felzartamab for the Chinese market, a CD38 inhibitor for multiple myeloma, which could have a phase 3 data readout in 2023.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/17/2020

Market Cap

86,955,258

Shares Outstanding

191,910,000

Weighted SO

82,623,343

Total Employees

N/A

Upcoming Earnings

N/A

Beta

1.0780

Last Div

0.0000

Range

0.99-2.536

Chg

0.0700

Avg Vol

232166

Mkt Cap

86955258

Exch

NASDAQ

Country

CN

Phone

86 21 6057 8000

DCF Diff

-1.9651

DCF

3.1301

Div Yield

0.0000

P/S

35.0728

EV Multiple

6.0286

P/FV

0.3758

Div Yield %

0.0000

P/E

-0.6868

PEG

-0.0143

Payout

0.0000

Current Ratio

5.6741

Quick Ratio

5.7177

Cash Ratio

5.2000

DSO

369.2010

DIO

2268.5033

Op Cycle

2637.7043

DPO

4179.9252

CCC

-1542.2209

Gross Margin

1.1628

Op Margin

-44.6407

Pretax Margin

-52.2846

Net Margin

-52.9276

Eff Tax Rate

0.1114

ROA

-0.3598

ROE

-0.4514

ROCE

-0.3602

NI/EBT

1.0123

EBT/EBIT

1.1712

EBIT/Rev

-44.6407

Debt Ratio

0.0512

D/E

0.0779

LT Debt/Cap

0.0456

Total Debt/Cap

0.0723

Int Coverage

-7843.2494

CF/Debt

0.0000

Equity Multi

1.5208

Rec Turnover

0.9886

Pay Turnover

0.0873

Inv Turnover

0.1609

FA Turnover

0.2142

Asset Turnover

0.0068

OCF/Share

0.0000

FCF/Share

0.0000

Cash/Share

29.6620

OCF/Sales

0.0000

FCF/OCF

0.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.3758

P/B

0.3758

P/S

35.0728

P/E

-0.6868

P/FCF

0.0000

P/OCF

0.0000

P/CF

0.0000

PEG

-0.0143

P/S

35.0728

EV Multiple

6.0286

P/FV

0.3758

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation